Electronic health records: Implications for drug discovery

Lixia Yao, Yiye Zhang, Yong Li, Philippe Sanseau, Pankaj Agarwal

Research output: Contribution to journalReview article

28 Scopus citations

Abstract

Electronic health records (EHRs) have increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial progress recently, including increasing adoption of standards, improved medical vocabularies and enhancements in technical infrastructure for data sharing across healthcare providers. Although the progress is directly beneficial to patient care in a hospital or clinical setting, it can also aid drug discovery. In this article, we review three specific applications of EHRs in a drug discovery context: finding novel relationships between diseases, re-evaluating drug usage and discovering phenotype-genotype associations. We believe that in the near future EHR systems and related databases will impact significantly how we discover and develop safe and efficacious medicines.

Original languageEnglish (US)
Pages (from-to)594-599
Number of pages6
JournalDrug Discovery Today
Volume16
Issue number13-14
DOIs
StatePublished - Jul 2011

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Electronic health records: Implications for drug discovery'. Together they form a unique fingerprint.

  • Cite this

    Yao, L., Zhang, Y., Li, Y., Sanseau, P., & Agarwal, P. (2011). Electronic health records: Implications for drug discovery. Drug Discovery Today, 16(13-14), 594-599. https://doi.org/10.1016/j.drudis.2011.05.009